Back to News
Market Impact: 0.35
UK Is Urged to Overhaul Regulation of AI-Medical Devices
Source: Bloomberg
Artificial IntelligenceHealthcare & BiotechRegulation & LegislationTechnology & Innovation
A UK advisory panel said regulation of AI-enabled medical devices needs to change to improve patient protection. It recommended a staged approval process with continuous post-approval monitoring, which could raise compliance requirements and extend commercialization timelines for affected medtech and AI-healthcare companies.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
More News
- CNBC Daily Open: Apple's new iPhone bends. Bond vigilantes, not so much
- UBS CEO flags investor complacency as geopolitical and economic risks mount
- Inside India newsletter: India’s green push aims to boost energy security but exposes China dependency
- Teradyne at Goldman Sachs Communacopia + Technology Conference: ai push widens
- Samsung works to draw iPhone users to its foldables even as Apple enters the market
- SailPoint (SAIL) Q2 2027 Earnings Call Transcript